−0.5970USD
−9.21 MUSD
731.49 KUSD
13.57 M
About Mangoceuticals, Inc.
Sector
CEO
Jacob D. Cohen
Headquarters
Dallas
Website
Employees (FY)
3
Founded
2021
ISIN
US56270V1061
FIGI
BBG01CCMR9Q3
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MGRX is 0.2999 USD — it has increased by 6.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mangoceuticals, Inc. stocks are traded under the ticker MGRX.
MGRX stock is 12.69% volatile and has beta coefficient of −2.15. Check out the list of the most volatile stocks — is Mangoceuticals, Inc. there?
Yes, you can track Mangoceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
MGRX stock has risen by 20.15% compared to the previous week, the month change is a 68.86% rise, over the last year Mangoceuticals, Inc. has showed a 66.30% decrease.
MGRX net income for the last quarter is −2.57 M USD, while the quarter before that showed −1.80 M USD of net income which accounts for −42.71% change. Track more Mangoceuticals, Inc. financial stats to get the full picture.
No, MGRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MGRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mangoceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 3.00 employees. See our rating of the largest employees — is Mangoceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mangoceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mangoceuticals, Inc. stock shows the strong sell signal. See more of Mangoceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mangoceuticals, Inc. EBITDA is −9.19 M USD, and current EBITDA margin is −1.26 K%. See more stats in Mangoceuticals, Inc. financial statements.